146 related articles for article (PubMed ID: 15868912)
1. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix.
Harisi R; Dudás J; Tímár F; Pogány G; Paku S; Tímár J; Kovalszky I; Szendroi M; Jeney A
Anticancer Res; 2005; 25(2A):805-13. PubMed ID: 15868912
[TBL] [Abstract][Full Text] [Related]
2. Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers.
Harisi R; Dudás J; Pogány G; Timár F; Oláh JN; Szendroi M; Jeney A
Cancer Chemother Pharmacol; 2006 Sep; 58(3):334-42. PubMed ID: 16534616
[TBL] [Abstract][Full Text] [Related]
3. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture.
Harisi R; Dudás J; Timár F; Pogány G; Timár J; Kovalszky I; Szendroi M; Jeney A
Cell Biol Int; 2005 Nov; 29(11):959-67. PubMed ID: 16242975
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts.
Sotobori T; Ueda T; Myoui A; Yoshioka K; Nakasaki M; Yoshikawa H; Itoh K
Exp Cell Res; 2006 Nov; 312(19):3927-38. PubMed ID: 17022972
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix induces doxorubicin-resistance in human osteosarcoma cells by suppression of p53 function.
Harisi R; Dudas J; Nagy-Olah J; Timar F; Szendroi M; Jeney A
Cancer Biol Ther; 2007 Aug; 6(8):1240-6. PubMed ID: 17703109
[TBL] [Abstract][Full Text] [Related]
8. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.
Nathan SS; DiResta GR; Casas-Ganem JE; Hoang BH; Sowers R; Yang R; Huvos AG; Gorlick R; Healey JH
Clin Cancer Res; 2005 Mar; 11(6):2389-97. PubMed ID: 15788690
[TBL] [Abstract][Full Text] [Related]
9. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
10. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin.
Chakkalakal DA; Mollner TJ; Bogard MR; Fritz ED; Novak JR; McGuire MH
Cancer Biochem Biophys; 1999 Jul; 17(1-2):89-98. PubMed ID: 10738905
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
12. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Fromigué O; Hamidouche Z; Marie PJ
J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
[TBL] [Abstract][Full Text] [Related]
13. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions.
Nikitovic D; Zafiropoulos A; Tzanakakis GN; Karamanos NK; Tsatsakis AM
Anticancer Res; 2005; 25(4):2851-6. PubMed ID: 16080537
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
[TBL] [Abstract][Full Text] [Related]
15. Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.
Muff R; Nigg N; Gruber P; Walters D; Born W; Fuchs B
Anticancer Res; 2007; 27(6B):3973-9. PubMed ID: 18225558
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
17. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
18. Effect of ethanol on human osteosarcoma cell proliferation, differentiation and mineralization.
Vignesh RC; Sitta Djody S; Jayasudha E; Gopalakrishnan V; Ilangovan R; Balaganesh M; Veni S; Sridhar M; Srinivasan N
Toxicology; 2006 Mar; 220(1):63-70. PubMed ID: 16406255
[TBL] [Abstract][Full Text] [Related]
19. The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules.
Erikson A; Tufto I; Bjønnum AB; Bruland ØS; Davies Cde L
Anticancer Res; 2008; 28(6A):3557-66. PubMed ID: 19189635
[TBL] [Abstract][Full Text] [Related]
20. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
